[{"address1": "9237 East Via de Ventura Boulevard", "address2": "Suite 105", "city": "Scottsdale", "state": "AZ", "zip": "85258", "country": "United States", "phone": "480 434 6670", "website": "https://journeymedicalcorp.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also offers Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Exelderm for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Emrosi for the treatment of inflammatory lesions of rosacea, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.", "fullTimeEmployees": 41, "companyOfficers": [{"maxAge": 1, "name": "Dr. Lindsay Allan Rosenwald M.D.", "age": 69, "title": "Executive Chairman", "yearBorn": 1955, "fiscalYear": 2024, "totalPay": 50000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Claude  Maraoui", "age": 57, "title": "Founder, President, CEO & Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 975434, "exercisedValue": 0, "unexercisedValue": 4806250}, {"maxAge": 1, "name": "Mr. Joseph M. Benesch", "age": 57, "title": "CFO & Corporate Controller", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 434088, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ramsey  Alloush", "age": 38, "title": "COO, General Counsel & Company Secretary", "yearBorn": 1986, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Nevin", "age": 55, "title": "Chief Commercial Officer", "yearBorn": 1969, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Jaclyn  Jaffe", "title": "Senior Director of Corporate Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Louis  Donati", "title": "Director of Market Access", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 10, "compensationRisk": 7, "shareHolderRightsRisk": 10, "overallRisk": 10, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.3, "open": 7.25, "dayLow": 7.1701, "dayHigh": 7.43, "regularMarketPreviousClose": 7.3, "regularMarketOpen": 7.25, "regularMarketDayLow": 7.1701, "regularMarketDayHigh": 7.43, "payoutRatio": 0.0, "beta": 0.794, "forwardPE": -122.16667, "volume": 68151, "regularMarketVolume": 68151, "averageVolume": 139448, "averageVolume10days": 71210, "averageDailyVolume10Day": 71210, "bid": 5.2, "ask": 9.35, "bidSize": 2, "askSize": 2, "marketCap": 192851152, "fiftyTwoWeekLow": 3.535, "fiftyTwoWeekHigh": 8.9, "allTimeHigh": 10.2, "allTimeLow": 1.02, "priceToSalesTrailing12Months": 3.4195285, "fiftyDayAverage": 7.277, "twoHundredDayAverage": 6.2942, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 183676096, "profitMargins": -0.15494001, "floatShares": 12808299, "sharesOutstanding": 20309844, "sharesShort": 1506808, "sharesShortPriorMonth": 1445130, "sharesShortPreviousMonthDate": 1755216000, "dateShortInterest": 1757894400, "sharesPercentSharesOut": 0.0573, "heldPercentInsiders": 0.32661998, "heldPercentInstitutions": 0.32595003, "shortRatio": 9.93, "shortPercentOfFloat": 0.1011, "impliedSharesOutstanding": 26309844, "bookValue": 0.82, "priceToBook": 8.939024, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -8738000, "trailingEps": -0.37, "forwardEps": -0.06, "enterpriseToRevenue": 3.257, "enterpriseToEbitda": -62.56, "52WeekChange": 0.16534185, "SandP52WeekChange": 0.17904854, "quoteType": "EQUITY", "currentPrice": 7.33, "targetHighPrice": 13.0, "targetLowPrice": 10.0, "targetMeanPrice": 12.0, "targetMedianPrice": 12.5, "recommendationMean": 1.25, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 20293000, "totalCashPerShare": 0.832, "ebitda": -2936000, "totalDebt": 25277000, "quickRatio": 0.888, "currentRatio": 1.266, "totalRevenue": 56397000, "debtToEquity": 131.336, "revenuePerShare": 2.567, "returnOnAssets": -0.058590002, "returnOnEquity": -0.57221, "grossProfits": 37517000, "freeCashflow": -14288125, "operatingCashflow": -2706000, "revenueGrowth": 0.01, "grossMargins": 0.66523004, "ebitdaMargins": -0.052059997, "operatingMargins": -0.19162, "financialCurrency": "USD", "symbol": "DERM", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "fiftyTwoWeekLowChangePercent": 1.0735501, "fiftyTwoWeekRange": "3.535 - 8.9", "fiftyTwoWeekHighChange": -1.5699997, "fiftyTwoWeekHighChangePercent": -0.17640446, "fiftyTwoWeekChangePercent": 16.534185, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1636727400000, "fiftyDayAverageChange": 0.052999973, "fiftyDayAverageChangePercent": 0.0072832173, "twoHundredDayAverageChange": 1.0358, "twoHundredDayAverageChangePercent": 0.1645642, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-11-12", "averageAnalystRating": "1.3 - Strong Buy", "postMarketChangePercent": 0.0, "postMarketPrice": 7.33, "postMarketChange": 0.0, "regularMarketChange": 0.0299997, "epsTrailingTwelveMonths": -0.37, "epsForward": -0.06, "earningsTimestamp": 1755028800, "earningsTimestampStart": 1762977600, "earningsTimestampEnd": 1762977600, "earningsCallTimestampStart": 1755030600, "earningsCallTimestampEnd": 1755030600, "isEarningsDateEstimate": false, "regularMarketDayRange": "7.1701 - 7.43", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 139448, "fiftyTwoWeekLowChange": 3.7949998, "corporateActions": [], "postMarketTime": 1759522204, "regularMarketTime": 1759521601, "cryptoTradeable": false, "shortName": "Journey Medical Corporation", "longName": "Journey Medical Corporation", "marketState": "CLOSED", "regularMarketChangePercent": 0.410955, "regularMarketPrice": 7.33, "exchange": "NCM", "messageBoardId": "finmb_280596341", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "trailingPegRatio": null, "__fetch_time": "2025-10-04"}]